Literature DB >> 23227283

The 2012 ACCF/AHA Focused Update of the Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Guideline: a critical appraisal.

Hani Jneid1.   

Abstract

The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) recently published the 2012 ACCF/AHA Focused Update of the Guidelines for the Management of Patients with Unstable Angina and Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Update).(1) These guidelines were developed in collaboration with multiple societies and represent an important landmark in the management of patients with unstable angina (UA) and non-ST-elevation myocardial infarction (NSTEMI). This paper provides a critical overview of some of the clinically relevant novel and modified recommendations proposed by the updated guideline.

Entities:  

Keywords:  P2Y12 receptor inhibitors; acute coronary syndrome; antiplatelet; clopidogrel; invasive strategy; myocardial infarction; prasugrel; revascularization; ticagrelor; unstable angina

Mesh：

Year:  2012        PMID： 23227283      PMCID： PMC3487574          DOI： 10.14797/mdcj-8-3-26

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


  22 in total

Review 1.  Advances in antiplatelet therapy.

Authors:  Hani Jneid; Deepak L Bhatt
Journal:  Expert Opin Emerg Drugs       Date:  2003-11       Impact factor: 4.191

2.  Early versus delayed invasive intervention in acute coronary syndromes.

Authors:  Shamir R Mehta; Christopher B Granger; William E Boden; Philippe Gabriel Steg; Jean-Pierre Bassand; David P Faxon; Rizwan Afzal; Susan Chrolavicius; Sanjit S Jolly; Petr Widimsky; Alvaro Avezum; Hans-Jurgen Rupprecht; Jun Zhu; Jacques Col; Madhu K Natarajan; Craig Horsman; Keith A A Fox; Salim Yusuf
Journal:  N Engl J Med       Date:  2009-05-21       Impact factor: 91.245

3.  Intensive versus conventional glucose control in critically ill patients.

Authors:  Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco
Journal:  N Engl J Med       Date:  2009-03-24       Impact factor: 91.245

4.  2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Hani Jneid; Jeffrey L Anderson; R Scott Wright; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Jeffrey L Anderson
Journal:  Circulation       Date:  2012-07-16       Impact factor: 29.690

5.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

6.  Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.

Authors:  Gregg W Stone; Michel E Bertrand; Jeffrey W Moses; E Magnus Ohman; A Michael Lincoff; James H Ware; Stuart J Pocock; Brent T McLaurin; David A Cox; M Zubair Jafar; Harish Chandna; Franz Hartmann; Franz Leisch; Ruth H Strasser; Martin Desaga; Thomas D Stuckey; Richard B Zelman; Ira H Lieber; David J Cohen; Roxana Mehran; Harvey D White
Journal:  JAMA       Date:  2007-02-14       Impact factor: 56.272

7.  Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda Weerakkody; C Michael Gibson; Elliott M Antman
Journal:  N Engl J Med       Date:  2007-11-04       Impact factor: 91.245

8.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

Authors:  Hans-Christoph Diener; Julien Bogousslavsky; Lawrence M Brass; Claudio Cimminiello; Laszlo Csiba; Markku Kaste; Didier Leys; Jordi Matias-Guiu; Hans-Jürgen Rupprecht
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

Review 9.  Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.

Authors:  Hani Jneid; Deepak L Bhatt; Roberto Corti; Juan J Badimon; Valentin Fuster; Gary S Francis
Journal:  Arch Intern Med       Date:  2003-05-26

10.  Early versus delayed, provisional eptifibatide in acute coronary syndromes.

Authors:  Robert P Giugliano; Jennifer A White; Christoph Bode; Paul W Armstrong; Gilles Montalescot; Basil S Lewis; Arnoud van 't Hof; Lisa G Berdan; Kerry L Lee; John T Strony; Steven Hildemann; Enrico Veltri; Frans Van de Werf; Eugene Braunwald; Robert A Harrington; Robert M Califf; L Kristin Newby
Journal:  N Engl J Med       Date:  2009-03-30       Impact factor: 91.245
View more
  6 in total

1.  Prognostic differences of catestatin among young and elderly patients with acute myocardial infarction.

Authors:  Wei-Xian Xu; Yuan-Yuan Fan; Yao Song; Xin Liu; Hui Liu; Li-Jun Guo
Journal:  World J Emerg Med       Date:  2022

Review 2.  Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies.

Authors:  Jie Ding; Hui Xu; Xiang Yin; Fu-rong Zhang; Xiao-ping Pan; Yi-an Gu; Jun-zhu Chen; Xiao-gang Guo
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

3.  Protection of cardiomyocytes from the hypoxia-mediated injury by a peptide targeting the activator of G-protein signaling 8.

Authors:  Motohiko Sato; Masahiro Hiraoka; Hiroko Suzuki; Miho Sakima; Abdullah Al Mamun; Yukiko Yamane; Takayuki Fujita; Utako Yokoyama; Satoshi Okumura; Yoshihiro Ishikawa
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

4.  Reduced Vitamin D Receptor on Circulating Endothelial Progenitor Cells: A New Risk Factor of Coronary Artery Diseases.

Authors:  Sidi Ai; Zhiqing He; Ru Ding; Feng Wu; Zhigang Huang; Jiamei Wang; Shuaibo Huang; Xianliang Dai; Jiayou Zhang; Jing Chen; Linlin Liu; Zonggui Wu; Chun Liang
Journal:  J Atheroscler Thromb       Date:  2017-11-24       Impact factor: 4.928

Review 5.  Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation?

Authors:  Christina G Perry; Alan R Shuldiner
Journal:  J Hum Genet       Date:  2013-05-23       Impact factor: 3.172

6.  Role of the ECG in initial acute coronary syndrome triage: primary PCI regardless presence of ST elevation or of non-ST elevation.

Authors:  B B L M IJkema; J J R M Bonnier; D Schoors; M J Schalij; C A Swenne
Journal:  Neth Heart J       Date:  2014-11       Impact factor: 2.380
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.